Welcome to LookChem.com Sign In|Join Free

CAS

  • or
FMOC-ALPHA-METHYL-L-SER, also known as N-(9-fluorenylmethoxycarbonyl)-α-methyl-L-serine, is a chemical compound that plays a significant role in the field of peptide synthesis. It is a derivative of alpha-methyl-L-serine, an amino acid involved in protein synthesis and acting as a precursor for the neurotransmitter glycine. The FMOC (9-fluorenylmethoxycarbonyl) group serves as a protecting group for the amino group, enabling selective reactions of the carboxylic acid functionality in peptide synthesis. FMOC-ALPHA-METHYL-L-SER is widely utilized in the development of peptide sequences for research and medical applications.

207117-28-0

Post Buying Request

207117-28-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

207117-28-0 Usage

Uses

Used in Pharmaceutical Industry:
FMOC-ALPHA-METHYL-L-SER is used as a building block for the synthesis of peptides, which are essential for the development of various pharmaceutical drugs. Its role in protein synthesis and as a precursor for glycine makes it a valuable component in creating therapeutic peptides.
Used in Research and Development:
FMOC-ALPHA-METHYL-L-SER is used as a key component in the solid-phase peptide synthesis process for research purposes. The protecting group allows for selective reactions, making it easier to create specific peptide sequences for studying their properties and potential applications.
Used in Biochemistry and Molecular Biology:
FMOC-ALPHA-METHYL-L-SER is utilized in the study of protein structure and function, as well as in the development of new techniques for peptide synthesis. Its role in neurotransmission also makes it a valuable tool for understanding the mechanisms of various biological processes.

Check Digit Verification of cas no

The CAS Registry Mumber 207117-28-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,1,1 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 207117-28:
(8*2)+(7*0)+(6*7)+(5*1)+(4*1)+(3*7)+(2*2)+(1*8)=100
100 % 10 = 0
So 207117-28-0 is a valid CAS Registry Number.

207117-28-0Downstream Products

207117-28-0Relevant articles and documents

Mucin architecture behind the immune response: Design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment

Martínez-Sáez, Nuria,Supekar, Nitin T.,Wolfert, Margreet A.,Bermejo, Iris A.,Hurtado-Guerrero, Ramón,Asensio, Juan L.,Jiménez-Barbero, Jesús,Busto, Jesús H.,Avenoza, Alberto,Boons, Geert-Jan,Peregrina, Jesús M.,Corzana, Francisco

, p. 2294 - 2301 (2016)

A tripartite cancer vaccine candidate, containing a quaternary amino acid (α-methylserine) in the most immunogenic domain of MUC1, has been synthesized and examined for antigenic properties in transgenic mice. The vaccine which is glycosylated with GalNAc at the unnatural amino acid, was capable of eliciting potent antibody responses recognizing both glycosylated and unglycosylated tumour-associated MUC1 peptides and native MUC1 antigen present on cancer cells. The peptide backbone of the novel vaccine presents the bioactive conformation in solution and is more resistant to enzymatic degradation than the natural counter part. In spite of these features, the immune response elicited by the unnatural vaccine was not improved compared to a vaccine candidate containing natural threonine. These observations were rationalized by conformational studies, indicating that the presentation and dynamics of the sugar moiety displayed by the MUC1 derivative play a critical role in immune recognition. It is clear that engineered MUC1-based vaccines bearing unnatural amino acids have to be able to emulate the conformational properties of the glycosidic linkage between the GalNAc and the threonine residues. The results described here will be helpful to the rational design of efficacious cancer vaccines.

SELENOCYSTINE DERIVATIVES, ALPHA-METHYLSELENOCYSTEINE, ALPHA-METHYLSELENOCYSTEINE DERIVATIVES, AND METHODS OF MAKING AND USING SAME

-

Paragraph 0086, (2016/08/29)

Provided are selenocysteine derivatives (e.g., deuterium and tritium analogs), α-methylselenocysteine, and α-methylselenocysteine derivatives. These compounds can be incorporated in more complex chemical structures (e.g., polymers, proteins, peptides, and

Synthesis of a new conformationally constrained glycoamino acid building block

Avenoza, Alberto,Peregrina, Jesús M.,San Martín, Emilio

, p. 6413 - 6416 (2007/10/03)

The synthesis of a suitably protected β-D-glucopyranosyl-(S)-α-methylserine derivative - a new conformationally constrained glycosylated quaternary amino acid analogue of β-D-glucopyranosyl-L-serine - is described. This compound can be used as an attractive building block for the synthesis of new, constrained glycopeptides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 207117-28-0